BioSig Technologies Inc. (BSGM) Presenting at 2nd Annual LD Micro Virtual Conference
BioSig Technologies (NASDAQ: BSGM) is a medical technology company developing a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace. BioSig Technologies is preparing to commercialize its PURE EP System, a novel cardiac signal acquisition and display system engineered to assist electrophysiologists in clinical decision-making during procedures to diagnose and treat patients with abnormal heart rates and rhythms. BioSig’s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. For more information, visit the company's website at www.biosigtech.com. About NetworkNewsWire NetworkNewsWire (NNW) is…